Breaks Categories: News

ThursdayFeb 11, 2021 11:02 am

NetworkNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd.’s (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Hemp-Based Substitute Mimics Traditional Tobacco Cigarette Experience

TAAT(TM) (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) today announced that, in a world where re-invented consumer packaged goods (“CPG”) of perceived unhealthy or environmentally harmful products are all the rage, the company is attempting to forge its own niche. TAAT is introducing a hemp-based substitute that mimics the experience of a traditional tobacco cigarette in an attempt to steal market share from Big Tobacco, as well as grow sales organically. The company’s cigarettes are formulated using a house blend of CBD-containing hemp called Beyond Tobacco(TM). Hemp is blended with patented ingredients and refined to replicate the experience of a conventional…

Continue Reading

ThursdayFeb 11, 2021 10:16 am

NetworkNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Announces Ability to Speed Up COVID-19 Testing Using PCR Equipment

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator at the leading-edge of the life science industry, has partnered with a German diagnostics firm to become a leader in commercializing breakthrough tech in rapid, definitive testing for COVID-19 in strategic and convenient point-of-care (“POC”) settings. A recent article noted that, using standard polymerase chain reaction (“PCR”) equipment, XPhyto has the ability to significantly speed up testing for COVID-19. The equipment is commonly found in most analytical laboratories as well as hospitals and a range of POC settings. The announcement was based on the successful trial validation results of XPhyto’s…

Continue Reading

ThursdayFeb 11, 2021 10:13 am

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces $7.4M Registered Direct Offering

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced its entry into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of approximately 4,222,288 shares of its common stock. The company expects gross proceeds of approximately $7.4 million, with each of the shares sold a purchase price of $1.75, in the registered direct offering priced at-the-market under Nasdaq rules. Predictive Oncology has also agreed to issue to the investors unregistered warrants to purchase up to an aggregate of approximately 2,111,114 shares…

Continue Reading

ThursdayFeb 11, 2021 9:48 am

NetworkNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Conference Call to Focus Fiscal Q3 2021 Business Results

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters, and CBD-infused products, has announced an upcoming conference call. The Feb. 16, 2021 call is scheduled to start at 5 p.m. ET and will discuss financial results and business updated for fiscal third-quarter 2021. The call will be hosted by WTER president and CEO Richard Wright and chief financial officer David Guarino. The company noted that the teleconference will include investors and analysts. Following the call, the company will also release its financial results and business update; the same information will be posted on…

Continue Reading

ThursdayFeb 11, 2021 9:13 am

NetworkNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Closes on Private Placement, Resulting in C$5.3 Million

PowerBand Solutions’ (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) has announced that the company has closed on its previously announced nonbrokered private placement. As announced on Jan. 22, 2021, the placement was comprised 18,275,862 units; each unit, which included one common share of the company and one share purchase warrant of the company, was sold at $0.29. In addition, each warrant holder allows the holder to receive on common share for no additional consideration for an exercise price of $0.49 per share for up to 24 months after their date of issuance. The private placement was fully subscribed, resulting in total…

Continue Reading

WednesdayFeb 10, 2021 1:59 pm

NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Secures $24.2M in Initial Public Offering

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company that offers novel and proprietary alternatives for treating mild-to-moderate obstructive sleep apnea, has closed its initial public offering of 4,025,000 shares of its common stock, including an additional 525,000 shares per the full exercise of the over-allotment option granted to the underwriters. According to the update, Vivos Therapeutics secured approximately $24.2 million in gross proceeds, with each of the shares sold at the public offering price of $6.00. The common stock shares began trading on the Nasdaq Capital Market under the ticker symbol "VVOS" on Friday, Dec. 11, 2020. ROTH Capital Partners…

Continue Reading

WednesdayFeb 10, 2021 1:53 pm

NetworkNewsBreaks – Knightscope Inc. Secures Order from Aerospace Client

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced its receipt of a purchase order from a privately held American aerospace and national security contractor. According to the update, the company is excited to provide an innovative solution for the new client for an undisclosed mission at an undisclosed location. To view the full update, visit https://nnw.fm/BtyzN About Knightscope Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security robots (“ASRs”) that deter, detect and report. The company’s long-term ambition is to make the United States of…

Continue Reading

WednesdayFeb 10, 2021 1:38 pm

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Achieves Record-Breaking Revenue for January 2021

PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced record monthly gross revenue of $1,089,502 for January 2021. According to the update, January 2021’s revenue increased as compared to results for the month of December 2020 and during the highly dynamic holiday season, when the company achieved gross revenue of $1,029,883. January revenue exceeded management's expectations given that e-commerce sales were expected to be slower following the holiday season. This success during one of the slowest e-commerce periods of the year highlights the tremendous impact PlantX continues to have in the plant-based marketplace. "It is truly encouraging to…

Continue Reading

WednesdayFeb 10, 2021 1:18 pm

NetworkNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) CEO Guest on Latest The Bell2Bell Podcast Episode

Uranium Energy (NYSE American: UEC) president and CEO Amir Adnani is the featured guest on the most recent episode of The Bell2Bell Podcast. Hosted by Stuart Smith, The Bell2Bell Podcast, which is an InvestorBrandNework offering, provides insightful updates and inspiring interviews with executives operating in fast-moving industries. During his segment, Adnani provided an overview of UEC’s business model, noting that the company develops uranium projects using the in-situ recovery method, which is both low cost and environmentally friendly. Adnani talked about a few of the company’s projects and operations, including its fully licensed Hobson Processing Facility, one of only a…

Continue Reading

WednesdayFeb 10, 2021 12:53 pm

NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Releases Q3 Financial Report

Canopy Rivers (TSX: RIV) (OTC: CNPOF), an investment and acquisition company specializing in cannabis, has shared financial numbers for its most recent period, the three and nine months ended Dec. 31, 2020. The announcement included both unaudited condensed interim consolidated financial statements and management's discussion and analysis ("MD&A"). Numbers in the report indicate that Canopy Rivers’ comprehensive income was $82.2 million, which the company notes was driven by an increase in the value of its investment in TerrAscend. The company also announced a “transformative and accretive” transaction with Canopy Growth; the transaction is scheduled to close by the end of February…

Continue Reading